76,000 Shares in Smith & Nephew plc (SNN) Purchased by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC bought a new position in shares of Smith & Nephew plc (NYSE:SNN) during the fourth quarter, Holdings Channel reports. The fund bought 76,000 shares of the medical equipment provider’s stock, valued at approximately $2,841,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of SNN. Oppenheimer Asset Management Inc. acquired a new stake in shares of Smith & Nephew during the fourth quarter worth about $52,000. Enlightenment Research LLC acquired a new stake in shares of Smith & Nephew during the fourth quarter worth about $52,000. Acadian Asset Management LLC acquired a new stake in shares of Smith & Nephew during the fourth quarter worth about $57,000. Lindbrook Capital LLC acquired a new stake in shares of Smith & Nephew during the fourth quarter worth about $68,000. Finally, Quadrant Capital Group LLC increased its position in shares of Smith & Nephew by 180.5% during the fourth quarter. Quadrant Capital Group LLC now owns 3,136 shares of the medical equipment provider’s stock worth $111,000 after purchasing an additional 2,018 shares in the last quarter. Institutional investors and hedge funds own 9.51% of the company’s stock.

Get Smith & Nephew alerts:

SNN has been the topic of a number of research analyst reports. JPMorgan Chase & Co. cut Smith & Nephew from an “overweight” rating to a “neutral” rating in a research report on Tuesday, January 1st. BNP Paribas cut Smith & Nephew from an “outperform” rating to a “neutral” rating in a research report on Friday, February 8th. Zacks Investment Research upgraded Smith & Nephew from a “sell” rating to a “hold” rating in a research report on Thursday, November 8th. Finally, Morgan Stanley upgraded Smith & Nephew from an “equal weight” rating to an “overweight” rating in a research report on Monday, December 10th. Six research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Smith & Nephew currently has an average rating of “Hold” and an average price target of $42.50.

Shares of SNN stock opened at $38.87 on Friday. The stock has a market capitalization of $16.69 billion, a P/E ratio of 19.24, a P/E/G ratio of 2.90 and a beta of 0.48. Smith & Nephew plc has a 52-week low of $32.22 and a 52-week high of $40.78. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.15 and a current ratio of 2.10.

The business also recently declared a semiannual dividend, which will be paid on Wednesday, May 8th. Investors of record on Friday, April 5th will be given a $0.44 dividend. This represents a yield of 2.31%. The ex-dividend date is Thursday, April 4th. This is a boost from Smith & Nephew’s previous semiannual dividend of $0.25. Smith & Nephew’s payout ratio is 26.73%.

TRADEMARK VIOLATION WARNING: “76,000 Shares in Smith & Nephew plc (SNN) Purchased by Sivik Global Healthcare LLC” was first published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/4194512/76000-shares-in-smith-nephew-plc-snn-purchased-by-sivik-global-healthcare-llc.html.

Smith & Nephew Company Profile

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Read More: What is Compound Annual Growth Rate (CAGR)?

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN).